Humana Inc. (HUM) exhibits 41.0% gross margins and 8.3% return on invested capital within Health Care (Medical Specialities), balanced against a 18.4x enterprise multiple and 6.5% implied options volatility.
Sustained 41.0% gross profitability converts into 2.1% operating margin and 8.3% ROIC, outpacing sector cost of capital.
ROIC: 8.3% // GM: 41.0%YoY revenue trajectory of +10.1% paired with 0.75% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +10.1% // FCF YLD: 0.75%Altman Z-Score of 5.03 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.03 // F-SCORE: 7/9Trading at 42.2x trailing P/E (39.2x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 42.2x // EV/EBITDA: 18.4xOptions market prices a ±6.5% implied move with a 0.65 put/call ratio around $409.00 max pain.
IMPL MOVE: ±6.5% // P/C: 0.65Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend 0.9% net margins.
NET MARGIN: 0.9% // D/E: 0.70x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for HUM & activate live FRED threshold breach alerts.